A phase III multicentre, double-blind, placebo-controlled study (TANGO) to evaluate CER-001 on carotid atherosclerosis (vessel wall area) in patients with familial primary hypoalph... von Stroes, E, Benghozi, R, Dasseux, J.L, Genest, J, Ginsberg, H, Keyserling, C, Leitersdorf, E, Raggi, P, von Eckardstein, A

Volltext

Recombinant human apolipoprotein-a-i prebeta-HDL (cer-001) promotes reverse cholesterol transport and reduces carotid wall thickness in patients with genetically-determined low HDL von Kootte, R.S, Smits, L.P, van der Valk, F.M, Dasseux, J.L, Keyserling, C, Barbaras, R, Paolini, J, Hovingh, G.K, van Dijk, T, Nederveen, A.J, Kastelein, J.J, Groen, A.K, Stroes, E.S

Volltext

Effects of CER-001 on carotid atherosclerosis by 3tmri in homozygous familial hypercholesterolemia (HoFH): The modifying orphan disease evaluation (mode) study von Hovingh, G.K, Stroes, E.S, Gaudet, D, Stefanutti, C, Soran, H, Kwok, S, de Graaf, J, Kastelijn, J.J.P, Frick, J, Klepp, H, Keyserling, C, Paolini, J, Dasseux, J.L

Volltext

Remodeling And Catabolism Of Cer-001 In Absence Of Lcat Enzyme von Ossoli, A., Strazzella, A., Simonelli, S., Rottoli, D., Abbate, M., Zoja, C.M., Dasseux, J.L., Calabresi, L.

Volltext

The amphipathic helix concept: length effects on ideally amphipathic LiKj(i=2j) peptides to acquire optimal hemolytic activity von Castano, Sabine, Cornut, Isabelle, Büttner, Klaus, Dasseux, J.L, Dufourcq, Jean

Volltext

The amphipathic helix concept: length effects on ideally amphipathic L iK j( i=2 j) peptides to acquire optimal hemolytic activity von Castano, Sabine, Cornut, Isabelle, Büttner, Klaus, Dasseux, J.L, Dufourcq, Jean

Volltext